Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
A new Kaiser Permanente research paper explains how Kaiser Permanente Northern California quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic.
Diabetes, medication safety, and understanding chronic conditions are just some of the research areas a new class of postdoctoral fellows at the Kaiser Permanente Northern California Division of Research will support. The 3 early-career researchers began their appointments this past year.
Partnership brings TPMG clinicians to the Division of Research to evaluate care and implement solutions; introducing the 2nd class of physician researchers, and their projects.
Kaiser Permanente's Northern California hospitals reduced hospitalizations and readmissions even as patients' conditions increased in severity, a new analysis shows.
A study in Annals of Surgical Oncology finds that the rate of home recovery after mastectomy increased from 23% regionwide to 61% in the 6 months after the program started, with no significant changes in emergency-department visits, reoperations, or readmissions.
A new machine learning algorithm developed by Kaiser Permanente researchers reveals the complexity of sepsis by sorting patients into recognizable treatment subgroups.
"As a first-year medical student, I enjoyed learning about the pathophysiology of disease. But as I gained more experience caring for patients suffering from these diseases, I realized I wanted to focus more on understanding the patient’s experience."
Seven early-career researchers began their post-doctoral appointments this past year and represent not only diverse communities but diverse research interests as well. This is Part 1 of our new class profile.
The Kaiser Permanente Division of Research has received a T32 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to train young scientists in translating research into practice for people with type 2 diabetes and prediabetes.